This inventor holds 1 USPTO granted patent. Top assignee: Ethypharm, Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Edouard André Gendrot: Innovator in Pharmaceutical Technology
Introduction
Edouard André Gendrot is a notable inventor based in Garnay, France. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of orally dispersible tablets. His innovative approach has led to advancements that enhance the usability and effectiveness of medications.
Latest Patents
Gendrot holds a patent for an "Orally dispersible tablet with low friability and method for preparing same." This invention focuses on a rapidly disintegrating tablet that dissolves in the mouth within 30 seconds upon contact with saliva. The tablet forms an easy-to-swallow suspension and is based on an active substance in the form of coated microcrystals or microgranules. The formulation includes a mixture of excipients, such as a disintegrating agent, a soluble agent, and a lubricating agent. Notably, the lubricating agent is in powder form and is primarily distributed on the tablet's surface. The friability of the tablet, measured according to the French Pharmacopoeia, is less than 1%, ensuring that the tablet can be packaged using standard processes without breaking during removal from its blister pack.
Career Highlights
Gendrot is associated with Ethypharm, Inc., where he continues to work on innovative pharmaceutical solutions. His expertise in creating formulations that improve patient compliance and medication delivery is highly regarded in the industry.
Collaborations
Throughout his career, Gendrot has collaborated with notable colleagues, including Laurent Di Costanzo and Mathieu Ernest Jean-Baptiste Di Costanzo. These collaborations have contributed to the advancement of pharmaceutical technologies and the development of effective drug delivery systems.
Conclusion
Edouard André Gendrot's contributions to the field of pharmaceutical technology, particularly through his patented orally dispersible tablet, demonstrate his commitment to innovation and improving patient experiences. His work continues to influence the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
